Aetna · SCS Hf 10 Burst · US health-plan appeal rights

SCS Hf 10 Burst denied due to quantity / dose limits by Aetna?

Q: How long do I have to appeal a Aetna SCS Hf 10 Burst denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Aetna typically requires

Aetna's specific coverage criteria for scs hf10 burst are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Aetna Clinical Policy Bulletin (SCS) + the applicable Clinical Policy Bulletin (Intrathecal Pumps) + the applicable Clinical Policy Bulletin (Back Pain Invasive) + the applicable Clinical Policy Bulletin (SI Joint)

The Aetna angle on SCS Hf 10 Burst

## Why Aetna Denied This — and Why It Is Worth Appealing

A quantity-limits denial for high-frequency (HF10) or burst-mode spinal cord stimulation typically arises in one of two scenarios: Aetna approved an SCS trial but is limiting the duration or number of trial sessions before authorizing permanent implant, or Aetna is restricting which components (leads, generators, programming sessions) will be covered. These limits are often applied mechanically by utilization-management tools and may not reflect the clinical reality of your case.

## The Clinical and Medical-Necessity Argument

Spinal cord stimulation is not a drug — "quantity limits" in this context usually means limits on the trial period or on covered hardware components. Your physician's determination of an adequate trial period and appropriate device configuration is a clinical judgment, not an administrative one. When an insurer's quantity limit conflicts with the treating physician's medical judgment about what is necessary to complete a safe and effective trial, that conflict is the heart of your appeal.

## Your Federal Appeal Rights

Fully-insured ACA plans are subject to external review under ACA §2719 after internal appeals are exhausted. Self-funded ERISA plans provide a full-and-fair review right under ERISA §503 and typically also offer external review. The external-review filing window is generally four months from the final internal denial. If the quantity limit is preventing care that is urgently needed, request an expedited review for a 72-hour decision.

## Appeal Timeline

1. File the Level 1 internal appeal immediately upon receiving the denial. 2. Request a peer-to-peer review between your implanting physician and Aetna's medical reviewer — this step alone resolves many quantity-limit disputes. 3. If unresolved, escalate to external review within the four-month window.

## Documentation to Gather

Physician justification letter: a detailed explanation of why the requested trial duration or component configuration is necessary, citing the physician's clinical assessment and applicable professional society guidance.
Clinical guidelines: your physician should reference the relevant professional society's guidance on trial adequacy (by organization name) to show the requested quantity is consistent with standard of care.
Device manufacturer documentation: the Instructions for Use and any clinical support documents that describe standard trial protocols.
Medical record documentation: objective measures of pain, function, and response during any trial period already completed.

## Criteria-Mapping Structure

Obtain Aetna's Clinical Policy Bulletin for SCS. Identify each criterion related to trial eligibility and duration. Map each criterion to a specific, documented fact from your records. If Aetna's limit is more restrictive than what the device's Instructions for Use or applicable professional society guidance supports, highlight that discrepancy explicitly in your appeal letter. Attach the supporting documents and submit as a single organized package.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Aetna appeals

Other denial reasons for Aetna SCS Hf 10 Burst

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.